BCL2
Apoptosis regulator Bcl-2
Also known as: Bcl-2, BCL2_HUMAN, PPP1R50
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10415
- Gene
- BCL2
- Ensembl
- ENSG00000171791
- Chromosome
- 18
- Canonical length
- 239 aa
- Protein class
- Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
239 residues, UniProt reviewed canonical sequence.
>P10415|BCL2
1 MAHAGRTGYD NREIVMKYIH YKLSQRGYEW DAGDVGAAPP GAAPAPGIFS SQPGHTPHPA
61 ASRDPVARTS PLQTPAAPGA AAGPALSPVP PVVHLTLRQA GDDFSRRYRR DFAEMSSQLH
121 LTPFTARGRF ATVVEELFRD GVNWGRIVAF FEFGGVMCVE SVNREMSPLV DNIALWMTEY
181 LNRHLHTWIQ DNGGWDAFVE LYGPSMRPLF DFSWLSLKTL LSLALVGACI TLGAYLGHKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BCL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 22 nTPM
- thymus: 17 nTPM
- spleen: 17 nTPM
- skeletal muscle: 16 nTPM
- lymph node: 14 nTPM
- tonsil: 14 nTPM
Single-cell type
- pituitary stem cells: 1,811 nCPM
- adipocytes: 1,139 nCPM
- melanocytes: 1,004 nCPM
- respiratory ionocytes: 902 nCPM
- salivary ionocytes: 900 nCPM
- schwann cells: 870 nCPM
Immune cell
- T-reg: 8.6 nTPM
- MAIT T-cell: 7.6 nTPM
- memory CD4 T-cell: 6.3 nTPM
- memory B-cell: 5.4 nTPM
- memory CD8 T-cell: 3.4 nTPM
- naive CD4 T-cell: 3.4 nTPM
Brain region
- medulla oblongata: 37 nTPM
- thalamus: 31 nTPM
- midbrain: 30 nTPM
- spinal cord: 30 nTPM
- basal ganglia: 29 nTPM
- hypothalamus: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BCL2.
Disease | ImmuneIEDB
Conditions an epitope on BCL2 was assayed in.
- breast cancer T cell
- skin melanoma T cell
ReferencesPubMed · IEDB
Publications for BCL2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
2007 · Dig Liver Dis · RCR 0.3 · 12 citations - Immunochemical studies of antigenic lymphoma-associated proteins.
2002 · Br J Haematol · RCR 0.1 · 6 citations - Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomas.
2009 · J Cancer Res Clin Oncol · RCR 0.1 · 2 citations
Reference: T cellIEDB
2 publications
- The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients.
2006 · Cancer Res · RCR 0.9 · 49 citations - Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade.
2022 · Front Immunol · RCR 0.2 · 3 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0.56
- gnomAD missense Z
- 1.4
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- apoptotic process
- autophagy
- axon regeneration
- axonogenesis
- B cell apoptotic process
- B cell homeostasis
- B cell lineage commitment
- B cell proliferation
- B cell receptor signaling pathway
- behavioral fear response
- branching involved in ureteric bud morphogenesis
- calcium ion transport into cytosol
- CD8-positive, alpha-beta T cell lineage commitment
- cell-cell adhesion
- cellular response to glucose starvation
- cellular response to hypoxia
- cochlear nucleus development
- defense response to virus
- dendritic cell apoptotic process
- digestive tract morphogenesis
- DNA damage response
- ear development
- endoplasmic reticulum calcium ion homeostasis
- epithelial cell apoptotic process
- extrinsic apoptotic signaling pathway in absence of ligand
- extrinsic apoptotic signaling pathway via death domain receptors
- female pregnancy
- focal adhesion assembly
- G1/S transition of mitotic cell cycle
- gland morphogenesis
- glomerulus development
- hair follicle morphogenesis
- hematopoietic stem cell differentiation
- homeostasis of number of cells within a tissue
- humoral immune response
- intrinsic apoptotic signaling pathway in response to DNA damage
- intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
- intrinsic apoptotic signaling pathway in response to oxidative stress
- lymphoid progenitor cell differentiation
- male gonad development
- melanocyte differentiation
- mesenchymal cell development
- metanephros development
- motor neuron apoptotic process
- myeloid cell apoptotic process
- negative regulation of anoikis
- negative regulation of apoptotic process
- negative regulation of apoptotic signaling pathway
- negative regulation of autophagy
- negative regulation of B cell apoptotic process
- negative regulation of calcium ion transport into cytosol
- negative regulation of cell growth
- negative regulation of cell migration
- negative regulation of dendritic cell apoptotic process
- negative regulation of epithelial cell apoptotic process
- negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
- negative regulation of G1/S transition of mitotic cell cycle
- negative regulation of intrinsic apoptotic signaling pathway
- negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
- negative regulation of mitochondrial depolarization
- negative regulation of motor neuron apoptotic process
- negative regulation of myeloid cell apoptotic process
- negative regulation of neuron apoptotic process
- negative regulation of ossification
- negative regulation of osteoblast proliferation
- negative regulation of retinal cell programmed cell death
- negative regulation of T cell apoptotic process
- neuron apoptotic process
- neuron maturation
- oocyte development
- organ growth
- ossification
- osteoblast proliferation
- ovarian follicle development
- positive regulation of apoptotic process
- positive regulation of B cell proliferation
- positive regulation of cell growth
- positive regulation of cell population proliferation
- positive regulation of melanocyte differentiation
- positive regulation of multicellular organism growth
- positive regulation of neuron maturation
- positive regulation of skeletal muscle fiber development
- positive regulation of smooth muscle cell migration
- post-embryonic development
- protein polyubiquitination
- reactive oxygen species metabolic process
- regulation of calcium ion transport
- regulation of cell-matrix adhesion
- regulation of gene expression
- regulation of glycoprotein biosynthetic process
- regulation of mitochondrial membrane permeability
- regulation of mitochondrial membrane potential
- regulation of nitrogen utilization
- regulation of protein localization
- regulation of protein stability
- regulation of viral genome replication
- release of cytochrome c from mitochondria
- renal system process
- response to cytokine
- response to gamma radiation
- response to glucocorticoid
- response to hydrogen peroxide
- response to iron ion
- response to ischemia
- response to nicotine
- response to radiation
- response to toxic substance
- response to UV-B
- response to xenobiotic stimulus
- retinal cell programmed cell death
- skeletal muscle fiber development
- smooth muscle cell migration
- spleen development
- stem cell development
- T cell apoptotic process
- T cell differentiation in thymus
- T cell homeostasis
- thymus development
- melanin metabolic process
- negative regulation of cellular pH reduction
- pigment granule organization
Molecular functions
- BH3 domain binding
- channel activity
- channel inhibitor activity
- DNA-binding transcription factor binding
- identical protein binding
- molecular adaptor activity
- protease binding
- protein heterodimerization activity
- protein phosphatase 2A binding
- sequence-specific DNA binding
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Bcl2-like
- Apoptosis regulator, Bcl-2 protein, BH4
- Apoptosis regulator, Bcl-2/ BclX
- Apoptosis regulator, Bcl-2, BH1 motif, conserved site
- Apoptosis regulator, Bcl-2, BH2 motif, conserved site
- Apoptosis regulator, Bcl-2, BH3 motif, conserved site
- Apoptosis regulator, Bcl-2, BH4 motif, conserved site
- Bcl-2 family
- Bcl-2-like superfamily
- Bcl-2, Bcl-2 homology region 1-3
- Apoptosis regulator proteins, Bcl-2 family
- Bcl-2 homology region 4
- Apoptosis regulator, Bcl-2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BCL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BCL2 as an antibody target. Whether an autoantibody or antibody against BCL2 could matter depends on whether native BCL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BCL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BCL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...